Levamisole in the treatment of E.N.L. in leprosy.
D000818:Animals; D002986:Clinical Trials as Topic; D004893:Erythema Nodosum / Q000188:drug therapy*; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D007918:Leprosy / Q000188:drug therapy* / Q000276:immunology; D007978:Levamisole / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000187:drug effects; D008262:Macrophage Activation / Q000187:drug effects; D051379:Mice
D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D007978:Levamisole